Feedback / Questions
BW-40202 - Argo Biopharma
https://www.prnewswire.com/news-releases/argo-biopharma-receives-ind-approval-from-nmpa-for-phase-ii-clinical-trial-of-sirna-therapy-bw-40202-for-the-treatment-of-pnh-302556225.html
Sep 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next